|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1985-5-17
|
|
pubmed:abstractText |
Photoradiation therapy is emerging as a promising technique for combating cancer. Fundamentally, this approach consists of two steps: hematoporphyrin derivative (HPD) is used to selectively sensitize cancer cells to visible light; after an appropriate time interval, light is introduced into the tumor via a laser-fiber optic system to trigger the cytotoxic action of HPD. The present investigation was initiated to determine the therapeutic potential of HPD in combination with a chemiluminescent activator in treating mice which had been transplanted with tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0361-7742
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
170
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
563-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6241697-Animals,
pubmed-meshheading:6241697-Female,
pubmed-meshheading:6241697-Hematoporphyrin Derivative,
pubmed-meshheading:6241697-Hematoporphyrins,
pubmed-meshheading:6241697-Luminescent Measurements,
pubmed-meshheading:6241697-Male,
pubmed-meshheading:6241697-Mammary Neoplasms, Experimental,
pubmed-meshheading:6241697-Mice,
pubmed-meshheading:6241697-Mice, Inbred C3H,
pubmed-meshheading:6241697-Naphthacenes,
pubmed-meshheading:6241697-Neoplasm Transplantation,
pubmed-meshheading:6241697-Oxamic Acid,
pubmed-meshheading:6241697-Photochemotherapy
|
|
pubmed:year |
1984
|
|
pubmed:articleTitle |
Effects of hematoporphyrin (HPD) and a chemiluminescence system on the growth of transplanted tumors in C3H/HeJ mice.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
